🇺🇸 FDA
Patent

US 10463652

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

granted A61KA61K31/428A61K31/437

Quick answer

US patent 10463652 (Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof) held by VTV THERAPEUTICS LLC expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/428, A61K31/437, A61K31/56, A61P